Sugi Predict

Sugi Predict / Compounds / SCHEMBL30567766

SCHEMBL30567766

SCHEMBL30567766

CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)O)C(C)C

nearest known ligand 0.72

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ TFPI P10646 5/20 0.63
▸ NPY2R P49146 8/20 0.62
▸ NPY4R P50391 8/20 0.62
▸ NPY5R Q15761 8/20 0.62
▸ NPY1R P25929 6/20 0.62
▸ EPHA2 P29317 2/20 0.59
▸ KDM1A O60341 2/20 0.58
▸ EP300 Q09472 1/20 0.58
▸ HIF1A Q16665 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30567738 0.92 NPY2R (0.68) TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL31276264 0.89 TFPI (0.64) TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL30906464 0.88 NPY2R (0.70) TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL29530732 0.88 NPY2R (0.66) TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL31000895 0.87 NPY2R (0.68) TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL31182752 0.87 NPY2R (0.69) TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL30888269 0.87 NPY2R (0.70) TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL31012331 0.87 MAPK8 (0.64) TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL30335722 0.87 TFPI (0.64) TFPINPY2RNPY4RNPY5RNPY1R
SCHEMBL30906476 0.87 NPY2R (0.71) TFPINPY2RNPY4RNPY5RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240277841-A2 HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-08-22 — — US disclosed
US-20240024473-A1 HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE PURDUE RESEARCH FOUNDATION (US) 2024-01-25 — — US disclosed
CN-116601290-A Human chimeric antigen receptor neutrophils, compositions, kits and methods of use 普渡研究基金会 2023-08-15 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240277841-A2 HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE PBK, KIT, MYD88 TFPI 1593/4885NPY2R 3831/4885NPY4R 3873/4885
US-20240024473-A1 HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE PBK, KIT, MYD88 TFPI 1593/4885NPY2R 3831/4885NPY4R 3873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback